What does the future hold for single-use bioreactor technologies?
Biological drugs - novel and follow-on biologics (biosimilars)
Our investigation gives you business research and analysis with sales forecasts. It lets you assess projected sales at world market, submarket and national level to 2022.
You find discussions, opinion and analyses for disposable bioprocess products:
Stirred flexible fermentors
Non-stirred flexible systems
Stirred rigid equipment
Non-stirred rigid units
For more information please click the link below
What are leading companies doing? Our work discusses GE Healthcare, Thermo Scientific, Sartorius Stedim and others. You see where the industry is heading from 2012 onwards. Also, you consider needs of biopharma customers producing drugs and vaccines.
In addition to our overall market projection, you see forecasting of world submarkets to 2022, finding potential revenues:
Hardware modules and systems
Disposables and accessories.
What are the technological and commercial possibilities?
Our study predicts that the disposable bioreactors market will have strong growth from 2012 to 2022. There will be a shift away from traditional biomanufacturing systems as newer, more-convenient fermentation systems reach the biopharma industry. You see how.
With that report, you discover how the market can grow. You also see which segments - including national markets - could achieve fastest sales growth for the technology.
You can investigate the future of limited-use bioreactors now, finding revenue potentials and trends for the industry. Our work shows and explains.
This report offers you:
For Table of Contents and Sample Pages please click the link below
Visit our Report Store
For more details contact: